CMAB raises $34M for manufacturing upgrade

CMAB raises $34M for manufacturing upgrade
By: biot11 Posted On: April 02, 2018 View: 382

CMAB raises $34M for manufacturing upgrade

CMAB Biopharma Inc. (Suzhou, China) raised $34 million in a series B round led by new investor CD Capital. Also participating were C-Bridge Capital, Cormorant, Qianhai FoF Fund and Tigermed.

CMAB said it will upgrade its biologics production facilities and expand manufacturing capacity. The facilities will meet global GMP standards and will initially focus on manufacturing preclinical and early stage clinical supplies for companies in China and worldwide.

Spokesperson Fiona Peng said CMAB does not expect to need additional funding until it expands into a separate GMP manufacturing site, which could occur as soon as 2019.

CMAB is located at the Suzhou Industrial Park Biotech Development Co. Ltd. (BioBay) innovation hub in Suzhou.

CD Capital, Cormorant and Tigermed are new investors. The company raised $38 million in a series A round in January (see BioCentury, Jan. 19).

  Contact Us

Botawala Chambers , Fort-Mumbai

Tel : + (91) - 8484924178
Mail :
Business Hours : 9:30 - 5:30


Dailyagronews is a dedicated platform for Exclusive Agriculture News , Now stay in touch with latest happenings in Agriculture . This site is a work of team of technocrafts wanted to help the farming community by contributing something helpful to them. Join this unique platform by contributing the agro news , we will be happy to make it viral